Homology Medicines, Inc   Report issue

For profit Phase 1 Phase 2
Founded: Lexington MA United States (2015)
Status: Defunct (2023)

Organization Overview

First Clinical Trial
2019
NCT03952156
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Homology Medicines, Inc

Active Ingredients

Drugs in Phase 2 Trials (1)

hmi-102 (1 trial)

Drugs in Phase 1 Trials (1)

hmi-103 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Phenylketonurias (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2